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Improved interpretation of studies comparing methods of dietary
assessment: combining equivalence testing with the limits of agreement
Abstract

The aim of this study was to demonstrate the use of testing for equivalence in combination with the Bland and
Altman method when assessing agreement between two dietary methods. A sample data set, with eighty
subjects simulated from previously published studies, was used to compare a FFQ with three 24 h recalls
(24HR) for assessing dietary I intake. The mean I intake using the FFQ was 126·51 (sd 54·06) µg and using
the three 24HR was 124·23 (sd 48·62) µg. The bias was −2·28 (sd 43·93) µg with a 90 % CI 10·46, 5·89 µg.
The limits of agreement (LOA) were −88·38, 83·82 µg. Four equivalence regions were compared. Using the
conventional 10 % equivalence range, the methods are shown to be equivalent both by using the CI (−12·4,
12·4 µg) and the two one-sided tests approach (lower t=−2·99 (79 df), P=0·002; upper t=2·06 (79 df),
P=0·021). However, we make a case that clinical decision making should be used to set the equivalence limits,
and for nutrients where there are potential issues with deficiency or toxicity stricter criteria may be needed. If
the equivalence region is lowered to ±5 µg, or ±10 µg, these methods are no longer equivalent, and if a wider
limit of ±15 µg is accepted they are again equivalent. Using equivalence testing, acceptable agreement must be
assessed a priori and justified; this makes the process of defining agreement more transparent and results
easier to interpret than relying on the LOA alone.
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Abstract
The aim of this paper is to demonstrate the use of testing for equivalence in combination with the
Bland and Altman method when assessing agreement between two dietary methods. A sample
dataset, with 80 subjects simulated from previously published research, is used to compare a food
frequency questionnaire with three 24 hour recalls for assessing dietary iodine intake. The mean
iodine intake using the FFQ was 126.51µgSD54.06 and using the three 24 hour recalls
124.23µgSD48.62. The bias and 90% CI were ‐2.28µgSD43.93 with a 90%CI‐10.46, 5.89µg and a
limits of agreement ‐88.38, 83.82µg. Four equivalence regions were compared. Using the
conventional 10% equivalence range the methods are shown to be equivalent both by using the CI
(‐12.4, 12.4µg) and the two one sided tests approach (lower t=‐2.99(79df)P=0.002, upper
t=2.06(79df)P=0.021). However we make a case that clinical decision making should be used to set
the equivalence limits and for nutrients where there are potential issues with deficiency or toxicity
a stricter criteria may be needed. If the equivalence region is lowered to ±5µg, or±10µg, these
methods are no longer equivalent, and if a wider limit of ±15µg is accepted they are again
equivalent. Using equivalence testing acceptable agreement must be assessed a priori and
justified, this makes the process of defining agreement more transparent and results easier to
interpret than relying on the limits of agreement alone.
Introduction
The Bland and Altman (BA) method(1) has been routinely used for assessing relative agreement
between two dietary methods. The rationale for doing this, typically, is that while the reference
method, or gold standard, is deemed to be more accurate, it also has substantial participant
burden to complete and resources to analyse. Often, the Food Frequency questionnaire (FFQ)
method is compared against Food Records, either weighed or unweighed, or repeated 24hr
dietary recalls. Food frequency questionnaires are easier to implement, less burdensome for
participants to complete and less costly to analyse(2). It is necessary to demonstrate that FFQ
results are equivalent to a reference method before it can be used with confidence.
Interpretation of the results of the BA method is straightforward when it is clear that the methods
do not agree. In practice, this is defined by a large and statistically significant bias using a
dependent samples test (paired t test or Wilcoxon matched pairs test). However, difficulty arises
in determining equivalence of two dietary methods when they are shown by the BA method to be
in agreement. For example a bias of 837kJ with a limits of agreement of ‐5192kJ to 6865kJ was
defined as “reasonably acceptable” agreement in a study(3) comparing a FFQ to an estimated food
diary. Likewise, compared to a 24 hour recal a FFQ was reported to have a bias of 1091kJ with a
limit of agreement of ‐2792kJ to 4974kJ(4). This was described as “performing well”and was
considered to have “fair” or “adequate” agreement despite the large and statistically significant
bias and wide limits of agreement. These two examples demonstrate a lack of consideration on
what constitutes a clinically acceptable difference between dietary methods. The limits of
agreement in these studies encompass a range of intake between 7766kJ and 12056kJ, which is
the magnitude of intake that represents the entire recommended daily intake for an adult (i.e.
8400 to 11700kJ(5; 6)). This is clearly undesirable, yet appears to be the current practice in the
published nutrition literature. As Bland and Altman, themselves stated, “How far apart
measurements can be without leading to problems will depend on the use to which the result is
put, and is a question of clinical judgement. Statistical methods cannot answer such a question”(7).
The aim of this paper is to consider how two methods can be demonstrated as being equivalent
when the BA indicates agreement. Here, we make a case for combining formal testing of
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equivalence with the BA method for assessing agreement between methods. Performing a test of
equivalence requires an a priori assessment of what constitutes a clinically acceptable difference
between two methods. In this paper, we first consider how agreement is described in the nutrition
literature for validation of FFQs using the BA method. Secondly, we compare the use of
equivalence testing to the BA method for assessing agreement between two methods using an
original dataset. The emphasis of this paper is to demonstrate the need to be able to accurately
define what constitutes clinical agreement ‐ before being able to interpret the level of agreement
between these methods ‐ and to encourage the use of both methods in validation studies.
Methods
To identify a sample of FFQ validation literature describing agreement using the BA method, a
search of the database Web of Science (accessed 20th March 2015) was conducted. This search
returned 24847 citations for the initial Bland and Altman paper, of which 250 were identified
under the sub search for Food Frequency Questionnaire. We then selected the 10 papers with the
highest number of citations, available through our institutional subscriptions, which aimed to
validate an FFQ using the BA method.
To demonstrate equivalence testing and compare this with the BA method, a dataset consisting of
a random sample of 80 participants was simulated based on a previously published analysis using
the means of iodine intake assessed using the average of three repeated 24hr recalls and a FFQ
(3x24hrR 118.88µg SD48.95, FFQ 120.19µg SD55.98 and correlation 0.614; P<0.001)(8). The dataset
was simulated using the matrix and drawnorm commands in STATA (Version 12, STATA Inc,
College Stn, Tx). Simulated data was chosen, instead of the actual data, in this example to allow
data sharing without any ethical considerations. In addition the initial dataset was right skewed
and transformed for analysis and the simulated data is normally distributed to assist with
interpretation.
The agreement of methods was interpreted using both a BA limits of agreement and an
equivalence approach. Both methods advocate acceptance on the basis of a clinical decision,
however in the case of the equivalence approach this must be explicitly stated a priori(9).
The BA method(1) involves plotting the difference between the two methods against the average
of the two methods and examing the mean bias, determining the 95% CI of the bias and any trend
in the bias. The precision of the limits are rarely considered in interpreting the BA plot.
Interpreting the precision of the limits involves calculating and interpreting the 95% CI of the
upper and lower limit and is detailed with an example in the initial Bland and Altman paper(1).
Further reference to this on Martin Bland’s website (https://www‐
users.york.ac.uk/~mb55/meas/sizemeth.htm accessed 28th August 2015) demonstrates clearly
the effect of sample size on these estimates and emphasises that it is important not only to
consider the width of the limits of agreement (LOA), but also the precision with which these have
been estimated.
Equivalence testing was performed using the two one sided test (TOST) procedure(10) and also by
using the confidence interval approach(11). Both are valid approaches and the use of one or the
other depends on whether there is a preference for the use of a P value or CI. Equivalence testing
is widely used in the pharmaceutical industry where a new drug, which may have fewer side
effects or be less costly to produce, is compared to the standard drug to determine if the
therapeutic effect is equivalent within a predefined range(12). If differences in means ( ) are
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considered using a paired t test, as in the traditional framework, the intention is to demonstrate
that a new drug or method is different (generally with the aim of showing superiority). In this case,
the null hypothesis states that there is no difference between the treatments, while the alternate
hypothesis states that there is a difference. Based on this paradigm, established by Neyman and
0, or that there is insufficient evidence to
Pearson(13), it can only be demonstrated that
demonstrate that
0. What cannot be demonstrated is that 0 , that is the null hypothesis
cannot be proven. With a small sample size, it is difficult to show that
0 and an erroneous
conclusion that there is no difference (type 2 error) may be made, particularly if the difference is
small and the variance is large(14). In this situation we may conclude that the two methods agree as
we do not have adequate power to demonstrate the difference is statistically significant.
Alternatively for every there is a sample size where it can be demonstrated that
0,
regardless of whether this difference has any practical meaning. In this situation we may conclude
that the methods do not agree when the difference between them is actually to small to have any
clinical meaning. Thus, the statistical significance is unrelated to the practical or clinical
significance. When demonstrating equivalence, the hypotheses are reversed such that the null
states that there is a difference ( : | | ∆ , where is the difference between the methods and
∆ is the prespecified equivalence interval) and the alternative hypothesis is that of no difference (
: | | ∆) (15). Equivalence trials require an a priori specification of an acceptable equivalence
range. Determination of this range needs to be guided by clinical acceptability of the range of
measures. Wellek discusses arbitrary ranges when the equivalence range is unknown(9) and other
arbitrary decisions such as ±10% of the reference mean have been employed in the literature on
physical activity(16). In general this equivalence region is poorly defined. A review of 332 non
inferiority and equivalence pharmaceutical trials found that half of these considered 0.5SD or less
of the difference between treatments to be an “irrelevant” difference(17). While TOST is not the
most powerful equivalence test(9; 18), it’s relative ease of use and interpretation(15) make it the
preferred approach for nutritional applicatons.
Both the BA and Equivalence approaches are most easily interpreted visually. In our analysis, we
present the traditional BA plots with the equivalence intervals incorporated. The figures contain
the equivalence interval, as well as the 90% CI of the difference and the limits of agreement. These
figures can be plotted easily in most statistical packages or in Microsoft Excel. This approach is
adapted from the one proposed in the SAS macro “Concord” which presents a BA style plot, that
incorporates the equivalence interval and 90%CI instead of the LOA(19), and we also present the
results as confidence interval plots and in tabular form to show different options of presentation.
Given that we wish to provide practical guidelines on the conduct of equivalence tests we consider
their use in STATA (V12, StataCorp LP, College Station Tx), SAS (V9.3 SAS Inc, Cary NC), SPSS (V21,
IBM Corporation Armonk NY) and R(V3.2.1 www.cran.r‐project.org(20)) and instruction on the use
of each of these is considered in Appendix A. In this example, we considered four regions of
equivalence to demonstrate the proposed methodology and the differences between equivalence
and non equivalence. The four equivalence regions chosen for this example demonstrate how to
interpret clear equivalence, non equivalence and an intuitively ambiguous result.
Results
A summary of the ten validation studies identified from the literature review is provided in Table
1. Only three of the ten papers considered a priori what an acceptable difference between the
methods would be, while none of the authors discussed what was considered an acceptable LOA.
All papers reported and discussed the correlation coefficient as a method of establishing validity,
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although two discussed the limitations of this approach. In most cases the results were compared
only to other literature and no clinically defined or practical implications of the LOA were
discussed. Seven of the ten studies performed hypothesis testing (Wilcoxon, paired t test) to
determine if the mean difference between the methods was statistically significant.
Table 2 presents the results of the Bland and Altman comparisons and the equivalence tests for
the simulated data in tabular form. Figure 1 presents the Bland and Altman plots with the
equivalence intervals and 90%CI of the difference. Figure 2 presents the confidence interval plot,
Figure 2a shows a confidence interval plot expressing the x axis as the difference between the two
means, as is the traditional approach used for pharmaceutical trials. Figure 2b shows a confidence
interval plot expressed relative to the mean intake of iodine using the 3x24hrR, the two plots (2a
and 2b) are identical in interpretation, in this case the methods are equivalent if the 90% CI is
contained within the prespecified equivalence region. All equivalence methods show that the FFQ
is only considered to be equivalent to the 3x24hrR when the equivalence margin is set at 10% of
the mean of the 3x24hrR (12.24µg), or alternatively at 15µg. The methods are not equivalent
when the margin is set at 5µg. The methods are also not equivalent when the margin is set at
±10µg because although the mean difference meets the criteria on one side (the upper 90% CI
being 5.89 which is within the upper bound of 10µg), the lower bound is outside the range (‐
10.49µg < 10µg) and both sides must be within the region to meet the assumption of equivalence.
This is also reflected in the P values, both of which must be significant for equivalence to hold.
Commands and outputs for the tests in SAS, R, STATA and SPSS are shown in Appendix 1. Figure 3
shows the BA LOA plot with the 90% CI of the mean bias used for the equivalence testing and the
95% CIs of the upper and lower limits of agreement (numerically represented in Table 2).

Discussion
This paper demonstrates the use of assessing equivalence in dietary studies that compare two
methods for agreement. Equivalence is presented to be used in conjunction with the more
commonly applied Bland and Altman limits of agreement method. The advantage of the
equivalence method is that it requires the clinican to make an a priori assessment of what
represents agreement, rather than accepting or rejecting the LOA determined in the Bland and
Altman analysis a posteri. The equivalence approach can be assessed using confidence intervals,
either independently or in combination with a BA plot, or equivalence can be assessed in the
traditional paradigm of P values using two one sided tests (TOST).
Frequently, the agreement between two dietary methods is assessed using the Bland and Altman
analysis, and the decision whether or not to determine agreement is based on a dependent
samples test (paired t test or Wilcoxon matched pairs test). This approach was not advocated by
Bland and Altman and their initial paper that describes the method makes no reference to
hypothesis testing regarding the bias. Rather, the initial manuscript by Bland and Altman(1) states
“How far apart the measurements can be without causing difficulties will be a question of
judgement. Ideally, it should be defined in advance to help in the interpretation of the method
comparison and to choose the sample size(1).”
Discussion to date on what constitutes a clinical LOA in the nutrition literature is limited. For
example in the studies reviewed here many compared their LOA to other studies(21) but still with
no discussion on whether this was acceptable in practice. In addition, when assessing agreement
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the 95% CIs of the limits (as shown in Fig 3) are rarely considered. These can be wide particularly
for small datasets and should be reported, discussed and considered particularly when estimating
sample sizes, as advocated in the early BA literature. When only considering the LOA themselves
we may be prepared to accept that the measures agree however the interpretation of the 95% CIs
of the LOA suggests that we could have an upper LOA as high as 117.96µg or a lower LOA as low as
‐122.24µg with repeated sampling.
Judging what is an acceptable equivalence between two methods is not a trivial procedure.(17; 22)
Even in the pharmaceutical domain where equivalence tests are most often used, a systematic
review found that only 134 of 314 studies provided a rationale for the difference used(17). Given
the number of agreement studies published in the field of nutrition, it is necessary to be able to
determine the clinical, rather than just the statistical interpretation, of the results.
The question of what constitutes equivalence in the field of nutrition is complex. This may differ,
depending on the nutrient being assessed and the population that is being studied. In the case of
iodine, the estimated average requirement reported in the Australian Nutrient Reference Values is
100µg/day for adults, with a recommended daily intake of 150µg/day and an upper limit of
1100µg/day(23). Estimated average intakes in the Australian population based on the most recent
(2011‐12) Australian nationally representative Health Survey were 191µg in males and 152µg in
females(24). Therefore, for the general population, a 10% equivalence based on the mean of the
reference food record appears reasonable. In populations where intakes may be inadequate (for
example pregnant women(25; 26) and where the consequences of inadequacy have serious impacts
on health outcomes, more stringent equivalence limits may be warranted.
Consideration of why it is important to state the acceptable LOA or equivalence a priori is
warranted. While there was a large range of sample sizes in the studies presented here (n=61‐785)
these were selected as being the most cited and dietary validation studies can be conducted with
relatively small sample sizes (for example n=49(27)). This may lead to an erroneous acceptance of
the null hypothesis due to limited power to detect a difference in the traditional hypothesis test
(that is a type 2 error). In our particular example, the power to detect a mean difference of
2.28µg(SD43.93) with 80 subjects is only 0.084. In order for this difference (2.28µg with an SD of
43.93µg) to be statistically significant at an alpha of 0.05 with 80% power, a sample size of 2112
would be required. As the sample size increases, the probability of rejecting the null hypothesis in
the traditional null hypothesis testing framework increases, while smaller sample sizes result in
the opposite trend(15).
In this example, we consider only the paired t test for equivalence as it is generally the case that
two dietary assessment methods would be compared on the same subjects. Independent t test
methods also exist for both normally distributed and non normal data. It is often the case that
dietary intake data is skewed as was the case with the initial dataset on which the simulation used
in the present an analysis was based(8). Non normal data can be analysed using a similar approach
for either paired or independent data based on the robust t test of Yuen(28) in the “equivalence”
package in R. Log transformation can also be considered. In this case the interpretation relies on
backtransformation and the results represent the ratio of the two methods, generally expressed
as a percentage with absolute equivalence being 100%. SAS has a “dist=lognormal” option
in PROC TTEST where the TOST procedure is conducted which will convert output and produce
data based on the geometric (or backtransformed) mean. When backtransforming logarithmic
data, a difference of ±10% is approximately symmetrical, however wider limits will not be. For
example if the equivalence region chosen is ±20% this will correspond to a range of 80% to 125%
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when the ratio is backtransformed. This relationship must be considered when setting equivalence
limits with log transformed data. Log transformations are commonly used in pharmaceutical
equivalence testing and these concepts have been covered in the related literature(12). The
equivalence approach can also be applied to other hypothesis testing such as equivalence of
slopes or trend(29). In addition, multisample and multivariate tests have also been described but
are beyond the scope of what is covered here.
This paper is designed to assess methodological comparison studies based on agreement using an
example based on our previous research. There are other methods for judging the usefulness of
new dietary assessment tools such as the method of triads which we have employed previously(8)
or missclassification but they are not discussed here. Lombard and colleagues(30) provide a recent
review and recommendations on the use of other methods, specifically applicable to nutrient
assessment. The comparison of 3x24hrR to an FFQ outlined here is an example of an approach
which can be applied not only to dietary methodology but to other methods used in nutrition
practice and research which are commonly assessed for agreement using Bland and Altman
methodology. These include comparing resting energy expenditure prediction equations to
indirect calorimetry(31; 32; 33; 34), bioelectrical impedance analysers to dual energy x‐ray
absorptiometry for assessing body composition(35; 36; 37; 38) and in validating physical activity
assessment tools(39; 40; 41).
In summary we have introduced here an equivalence approach to be used in conjunction with the
Bland and Altman method in order to encourage clinicians to establish up front what constitutes a
clinically meaningful difference between the two methods being considered. This not only makes
interpretation of the results of the study clear but also assists with assessing the necessary sample
size in planning the study.
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Table 1. Summary of a highly cited sample of the literature assessing agreement of an FFQ with a reference method using the Bland and Altman method.
Paper and

Sample

Correlation

Significance

comparator

size

performed

test of

of acceptable

to assess

differences

agreement

method

BA plots presented

A priori assessment

Conclusion

Justifcation of conclusion

Number of
citations*

validity
Villegas et

195

yes

(21)

al 2007

Wilcoxon,

Energy, protein, fat,

100% of ratio of

all P<0.05.

carbohydrate, 8 nutrients not

FFQ/24 FR, no LOA

FFQ, 24HR
Matthys et

104

Yes

Wilcoxon,

No BA plots, mean difference

Nil

and SD presented

al 2007

FFQ/EFD

64

studies.

“acceptable for assessing population median

Acceptability based on

intakes” for some food groups. LOA “broad for

P≥0.05 in the Wilcoxon tests

43

all food groups”
83

Yes

Cullen et al
2007

Compared with other

shown

(42)

Weber

“good agreement”

Paired t

No BA plots, mean difference

tests

and SD presented

Nil

Based on paired t tests

65

LOA wide. Most means lower in FFQ. Three

Compared with other

48

BA plots done however not shown as they
“indicated no association between the

(43)

difference and the mean of the two measures”.

FFQ/24HR

Validity for some nutrients, but not most food
groups in adolescents based on t test.

Hjartaker et

238

Yes

Wilcoxon

(4)

Energy, fibre, alcohol, 20

Nil

al 2007

nutrients not shown, however

general trends in the bias over the range

studies. “overall relative

FFQ/24HR

the 3 figures were shown to

measured.

validity …comparable to that

represent 3 trends observed in

of FFQs used in other large

the nutrients assessed.

cohorts often described as
‘fair’ or ‘adquate’”.

Brantsæter
et al
2008

(44)

FFQ/WFD

119

Yes

Wilcoxon

Energy,

Nil

“Bias was small, whereas the confidence limits

Fruit/vegetable/juice(g/day),

were wide”

24

“..produces realistic and relatively precise

nutrients/vitamins/elements

estimate of habitual intake of energy”

not shown as “the plots were
similar to the plot of energy
intake”.

Based on small bias.

85

9
Toft et al
2008

264

(45)

FFQ/DH

Yes,

Wilcoxon by

Saturated fat, Energy, 19

although

sex, 38/42

nutrients not shown

limitations

P<0.05

Nil

“acceptable agreement” with “small

No definition of acceptable

differences”. Saturated fat tendency for

agreement given.

35

increased underreporting with increased intake.

discussed.
Watson et

113

Yes

No

(46)

al 2009

Β‐carotene, calcium, 20

Good (difference

“Not suitable for estimating absolute

Positive differences,

nutrients not shown

≈1SD mean

agreement”

Wide limits of agreement,

FFQ/AFR

59

reference)

increasing difference with

Fairly good

increasing bias.

(difference ≈2SD
mean reference)
Poor (difference
≈3SD mean
reference)
Zhang et al
2009

61

Yes

(47)

FFQ/EFD

Wilcoxon,

Energy, Vitamin C, 12

100% of ratio of

Differences stated no discussion on whether

Compared with other

however

nutrients not shown

FFQ/24 FR, no LOA

they agree with 100%, LOA similar or narrower

studies.

results not

to other studies. State BA plots show no linear

reported

trend and there is “reasonable comparative

42

validity”
Ambrosini

785

et al
2009

(48)

FFQ/EFD

Yes,

“The majority of nutrients showed average

“Most LOA ranged from 50‐

although

No

Energy, carbohydrate, protein,
fat, 18 nutrients not

Nil

agreement that was significantly different from

250%” similar to other

discussed

presented.

100%” however the criteria for significance was

studies.

limitations

not stated. 95% CIs are presented.
“agreement between these two methods was

Compared to other studies,

Ballart et al

product, potato, legumes,

also reasonably acceptable”. “It was found to

expected general

(3)

energy, protein, thiamine,

have acceptable levels of reproducibility and

overestimation by FFQ

cobalamin presented as

validity”

Fernández‐

2010

FFQ/EFD

158

Yes

39

No

Vegetable, meat/meat

examples showing no trend or
systematic trend over range of
values, 26 nutrients/foods not
shown

Nil

(49)

.

126

10
* number of citations on Web of Science on the 28th August 2015.
WFD weighed food diary, EFD estimated food diary 24HR, 24 hour recall, DH diet history, AFR assisted food record.
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Table 2. Summary statistics, paired t test, Bland and Altman LOA and equivalence tests for assessing agreement
between the 3 x 24hrR and the FFQ.
Iodine
Method (n=80)

(mean)

SD

Minimum

Maximum

3x24hrR

124.23 µg

48.62 µg

29.61µg

240.00µg

FFQ

126.51 µg

54.06 µg

13.03µg

244.82µg

Paired t test
Mean difference
3x24hrR -FFQ

95% Confidence Interval
SD

-2.28µg

43.93 µg

SEM

of the Difference

4.91 µg

-12.06 µg

7.49 µg

t (df=79)

P

-.465

.643

Bland and Altman Limits of Agreement

BA bias
-2.28 µg

SD
43.93 µg

SEM

Limits of Agreement

4.91 µg

-88.38 µg

83.82 µg

95% CI of

95% CI of

lower limit

upper limit

-122.24 µg,

49.96 µg,

-54.52 µg

117.96 µg

Paired equivalence test
Mean difference
3x24hrR -FFQ
-2.28 µg

90% Confidence Interval
SD
43.93 µg

SEM
4.91 µg

of the Difference
-10.46 µg

t (df=79)

P

5.89 µg

Equivalence region -2.28±5 µg iodine

t upper

0.55

0.291

-5 > -10.46, 5.89 > 5 DECISION: NOT EQUIVALENT

t lower

-1.48

0.071

Equivalence region -2.28±10 µg iodine

t upper

1.57

0.060

-10 > -10.46, 5.89 > 10 DECISION: NOT EQUIVALENT

t lower

-2.50

0.007

Equivalence region -2.28±15 µg iodine

t upper

2.59

0.006

-15 > -10.46, 5.89 > 15 DECISION: EQUIVALENT

t lower

-3.52

0.000

Equivalence region -2.28±10% (±12.4) µg iodine

t upper

2.06

0.021

-12.4 > -10.46, 5.89 > 12.4 DECISION: EQUIVALENT

t lower

-2.99

0.002

12

Fig. 1a. Equivalence ±5µg iodine

Fig. 1b. Equivalence ±10µg iodine

Fig. 1c. Equivalence ±10% mean iodine 3x24hrR

Fig. 1d. Equivalence ±15µg iodine

Fig. 1. Bland and Altman plots with superimposed equivalence intervals and the 90%CI of the mean
difference. 3 x 24hrR; average of 3 24 hour recalls, FFQ; food frequency questionnaire
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Lower 90%CI
‐10.46 µg

Upper 90%CI
5.89 µg

Mean diff (90% CI)

Equivalence (‐5µg, 5µg)

Equivalence (‐10µg, 10µg)

Equivalence (‐10%, 10%)

Equivalence (‐15µg, 15µg)

‐20

‐15

‐10
‐5
0
5
10
mean difference µg iodine

15

20

Fig. 2a. Confidence interval plot using the mean difference between the 3x24hrR and FFQ

Lower 90%CI
117 µg

Upper 90%CI
129µg

Mean (90% CI)

Equivalence (‐5µg, 5µg)

Equivalence (‐10µg, 10µg)

Equivalence (‐10%, 10%)

Equivalence (‐15µg, 15µg)

100 105 110 115 120 125 130 135 140 145 150
iodine (µg)

Fig. 2b. Confidence interval plot using the mean iodine intake in the 3x24hrR (124.23µg). 3 x 24hrR; average of 3
24 hour recalls, FFQ; food frequency questionnaire

Fig. 2. Confidence interval plots
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Bias

90% CI of mean difference

Fig. 3. 95% CI of the upper and lower Limits of Agreement for the mean bias in iodine intake (µg)
between the 3 x 24hrR and the FFQ
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Appendix 1, Supplementary online material.
Conducting the Equivalence test in different statistical packages. In these examples, equivalence at 5 and
15µg are shown to demonstrate the contrast output when the methods are determined to be equivalent
and when they are not equivalent. The dataset is also available on request (marijka@uow.edu.au) to
replicate the analyses.
1. R
In R equivalence testing can be conducted easily using the package “equivalence” (www.cran.rproject.org/web/packages/equivalence/equivalence.pdf)

The tost command (in bold) can be used for paired or independent data, by specifying a single variable the
paired test is used. The test is conducted on the bias, the difference between the methods. In this analysis
this variable is called “bias” and the dataset is called “iodine”. The bias is the difference between the
x24hrR (average of 3 24 hour recalls) and the FFQ (food frequency questionnaire)
tost(iodine$bias, y=NULL, alpha=0.05, epsilon=5)
$mean.diff
[1] 2.284939
$se.diff
[1] 4.91133
$alpha
[1] 0.05
$ci.diff
[1] -5.889338 10.459215
attr(,"conf.level")
[1] 0.9
$df
df
79
$epsilon
[1] 5
$result
[1] "not rejected"
$p.value
[1] 0.2909752
$check.me
[1] -0.430123 5.000000
attr(,"conf.level")
[1] 0.4180496
The P value is >0.05 (0.2909752) and indicates the methods are not equivalent.
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tost(iodine$bias, y=NULL, alpha=0.05, epsilon=15)
$mean.diff
[1] 2.284939
$se.diff
[1] 4.91133
$alpha
[1] 0.05
$ci.diff
[1] -5.889338 10.459215
attr(,"conf.level")
[1] 0.9
$df
df
79
$epsilon
[1] 15
$result
[1] "rejected"
$p.value
[1] 0.00572852
$check.me
[1] -10.43012 15.00000
attr(,"conf.level")
[1] 0.988543
The P value is <0.05 (0.00572852) and indicates the methods are equivalent.

2. In SAS V9.3 (SAS Inc, Cary NC), equivalence testing is available through the PROC TTEST procedure,
in SAS it is necessary to specify that the test is paired and the values for the FR and FFQ are used.
SAS also produces graphical output. As mentioned in the text, the SAS macro concord(19) produces
equivalence tests and Philip Dixon(29) provides syntax on determining equivalence using the PROC
MIXED procedure in an online archive EquivSlope.sas
http://www.esapubs.org/archive/ecol/E086/094/suppl‐1.htm
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Proc ttest data=iodine tost(-5,5);
paired FR*FFQ;
run;

The SAS System
The TTEST Procedure
Difference: FR - FFQ

N

Mean Std Dev Std Err Minimum Maximum

80 -2.2849 43.9283 4.9113

-119.8

76.2301

Mean 95% CL Mean Std Dev 95% CL Std Dev
-2.2849 -12.0607 7.4908 43.9283 38.0178 52.0318
TOST Level 0.05 Equivalence Analysis

Mean Lower Bound
-2.2849

90% CL Mean

Upper Bound Assessment

-5 > -10.4592 5.8893 >
Test

5 Not equivalent

Null DF t Value P-Value

Upper

-5 79

0.55

0.2910

Lower

5 79

-1.48

0.0710

Overall

0.2910

The P value is >0.05 (0.2910) and indicates the methods are not equivalent.
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Proc ttest data=iodine tost(-15,15);
paired FR*FFQ;
run;

The SAS System
The TTEST Procedure
Difference: FR - FFQ

N

Mean Std Dev Std Err Minimum Maximum

80 -2.2849 43.9283 4.9113

-119.8

76.2301

Mean 95% CL Mean Std Dev 95% CL Std Dev
-2.2849 -12.0607 7.4908 43.9283 38.0178 52.0318
TOST Level 0.05 Equivalence Analysis

Mean Lower Bound
-2.2849

90% CL Mean

Upper Bound Assessment

-15 < -10.4592 5.8893 <

Test

15 Equivalent

Null DF t Value P-Value

Upper

-15 79

2.59

0.0057

Lower

15 79

-3.52

0.0004

Overall

0.0057

The overall P value is less than 0.05 and indicates the methods are equivalent
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3. In STATA V12 (StataCorp LP, College Station, TX) equivalence tests are available through a user
written .ado file written by Alexis Dinno available from http://doyenne.com/stata/tost.html
tostt fr==ffq, eqvt(delta) eqvl(5)
Paired t test of mean equivalence
-----------------------------------------------------------------------------Variable |
Obs
Mean
Std. Err.
Std. Dev.
[95% Conf. Interval]
---------+-------------------------------------------------------------------fr |
80
124.2285
5.43549
48.6165
113.4094
135.0476
ffq |
80
126.5134
6.043544
54.0551
114.484
138.5428
---------+-------------------------------------------------------------------D-diff |
7.284939
4.91133
-2.490819
17.0607
diff+D |
2.715061
4.91133
-7.060696
12.49082
-----------------------------------------------------------------------------mean(diff) = mean(fr - ffq)
Delta (D) = 5.0000 Delta expressed in same units as fr
Impossible to reject any Ho if Delta <= t-crit*s.e. ( 8.174 ). See help tostt.
df = 79

Ho: |diff| >= Delta:
t1 = 1.483

t2 = .5528

Ho1: Delta-diff >= 0
Ha1: Delta-diff < 0
Pr(T > t1) = 0.0710

Ho2: diff+Delta <= 0
Ha2: diff+Delta > 0
Pr(T > t2) = 0.2910

Both P values must be significant for the methods to be equivalent, therefore not equivalent
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tostt fr==ffq, eqvt(delta) eqvl(15)
Paired t test of mean equivalence
-----------------------------------------------------------------------------Variable |
Obs
Mean
Std. Err.
Std. Dev.
[95% Conf. Interval]
---------+-------------------------------------------------------------------fr |
80
124.2285
5.43549
48.6165
113.4094
135.0476
ffq |
80
126.5134
6.043544
54.0551
114.484
138.5428
---------+-------------------------------------------------------------------D-diff |
17.28494
4.91133
7.509181
27.0607
diff+D |
12.71506
4.91133
2.939304
22.49082
-----------------------------------------------------------------------------mean(diff) = mean(fr - ffq)
Delta (D) = 15.0000 Delta expressed in same units as fr
df = 79
Ho: |diff| >= Delta:
t1 = 3.519

t2 = 2.589

Ho1: Delta-diff >= 0
Ha1: Delta-diff < 0
Pr(T > t1) = 0.0004

Ho2: diff+Delta <= 0
Ha2: diff+Delta > 0
Pr(T > t2) = 0.0057

Both P values must be significant for the methods to be equivalent, therefore equivalent
4. In SPSS V21 (IBM Corporation, Armonk NY) there is not an automated procedure to produce the
two one sided tests. This can be done manually by conducting two one sample t tests using the
upper and lower equivalence values and the bias as the test variable. This test only produces a two
tailed output of significance which needs to be halved for the one tailed P value. If both of these
are significant then the methods are equivalent. This can be demonstrated by comparing with the
STATA output above. Note that halving the P values is approximate, exact one sided P values could
be obtained from several free online calculators or by using R (for example 1-pt(3.519,
df=80) returns P=0.003588676.
T-TEST
/TESTVAL=-5
/MISSING=ANALYSIS
/VARIABLES=bias
/CRITERIA=CI(.95).
T-TEST
/TESTVAL=5
/MISSING=ANALYSIS
/VARIABLES=bias
/CRITERIA=CI(.95).
One-Sample Test
Test Value = -5
95% Confidence Interval of the
Difference

Mean
t
Bias

1.483

df

Sig. (2-tailed)
79

.142

Difference
7.28494

Lower
-2.4908

Upper
17.0607
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The P value of 0.142 must be halved to give 0.071 for the lower equivalence bound

One-Sample Test
Test Value = 5
95% Confidence Interval of the
Difference

Mean
t
Bias

df

-.553

Sig. (2-tailed)
79

Difference

.582

-2.71506

Lower

Upper

-12.4908

7.0607

The P value of 0.582 must be halved to give 0.291 for the upper equivalence bound. As neither of these are
significant at the 0.05 level, the methods are not equivalent.

T-TEST
/TESTVAL=-15
/MISSING=ANALYSIS
/VARIABLES=bias
/CRITERIA=CI(.95).
T-TEST
/TESTVAL=15
/MISSING=ANALYSIS
/VARIABLES=bias
/CRITERIA=CI(.95).

One-Sample Test
Test Value = -15
95% Confidence Interval of the
Difference

Mean
t
Bias

df

3.519

Sig. (2-tailed)
79

Difference

.001

17.28494

Lower

Upper

7.5092

27.0607

The P value of 0.001 must be halved to give P=0.0005 for the lower equivalence bound

One-Sample Test
Test Value = 15
95% Confidence Interval of the
Difference

Mean
t
Bias

-2.589

df

Sig. (2-tailed)
79

.011

Difference
-12.71506

Lower
-22.4908

Upper
-2.9393

The P value of 0.011 must be halved to give P=0.006 for the upper equivalence bound. As BOTH of these
tests are significant at the 0.05 level, the methods are equivalent.
The SPSS custom dialog box SPSS custom dialog developed by Weber & Popova(50) available from

http://www.medianeuroscience.org/equivalence_testing uses effect sizes based on Cohen’s d. In order to
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replicate the examples in this paper the equivalence bounds were converted to approximated effect
sizes(51) for the upper and lower bound using the pooled standard deviation of the difference between the
methods and correlation from the paired t test and then averaged to create an overall effect size for the 5
and 15 equivalent ranges. The default values for Cohen’s small, medium and large effect sizes are also
presented as an alternative approach.
For the equivalence bounds of (‐5,5) the approximated effect size is 0.1328
***

Weber & Popova Dependent/Paired-Samples Equivalence Procedure
Based on the custom-entered delta

Custom delta
____________

t
________

df
________

p based on
actual value of delta
(two-tailed)
_____________________

.133

-.47

79

.188

***

p based on
half variance explained
(two-tailed)
_______________________
.382

For the equivalence bounds of (‐15,15) the approximated effect size is 0.3734

***

Weber & Popova Dependent/Paired-Samples Equivalence Procedure
Based on the custom-entered delta

Custom delta
____________

t
________

df
________

p based on
actual value of delta
(two-tailed)
_____________________

.373

-.47

79

.000

***

p based on
half variance explained
(two-tailed)
_______________________
.038

Using the default Cohen’s effect sizes.
***

Weber & Popova Dependent/Paired-Samples Equivalence Procedure
Based on the Cohen's classification of effect sizes

t
________

df
________

Delta
________

p, two-tailed
_____________

-.47
-.47
-.47

79
79
79

.10
.30
.50

.291
.004
.000

***
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